Our study confirmed that the increased expression of the TIGAR can reverse the apoptosis by the combination of p53 and cisplatin, but this reversal is limited, and there may be other mechanisms that need to be explored for the regulation of the combination therapy on lung cancer cell apoptosis. The gene discussed is TP53; the disease is lung carcinoma.